Fiche publication
Date publication
décembre 2025
Journal
Vaccine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr THILLY Nathalie
Tous les auteurs :
Bocquier A, Cadoret S, Fall E, Bonnay S, LeDuc-Banaszuk AS, Branchereau M, Gauchet A, Bruel S, Gagneux-Brunon A, Giraudeau B, Michel M, Mueller JE, Lefèvre B, Thilly N,
Lien Pubmed
Résumé
Human papillomavirus vaccine coverage (HPV VC) remains suboptimal in many countries. French authorities launched the PrevHPV research program, which included a cluster randomized controlled trial (cRCT) to evaluate the effectiveness of an 'at-school vaccination' intervention. Within this trial, we conducted a process evaluation of this intervention, specifically analyzing (i) its implementation, (ii) its mechanisms of impact, and (iii) the contextual factors influencing implementation (facilitators/barriers).
Mots clés
Acceptability, Human papillomavirus, Implementation, Mixed-method study, School-based immunization program, Vaccination
Référence
Vaccine. 2025 12 17;72:128122